Improving Pneumococcal Vaccination Rates in an Inpatient Pediatric Diabetic Population.

IF 1.2 Q2 MEDICINE, GENERAL & INTERNAL
Aymen Mirza, Apoorva Jagadish, Kelsey Trimble, Adijat Olanrewaju
{"title":"Improving Pneumococcal Vaccination Rates in an Inpatient Pediatric Diabetic Population.","authors":"Aymen Mirza,&nbsp;Apoorva Jagadish,&nbsp;Kelsey Trimble,&nbsp;Adijat Olanrewaju","doi":"10.31486/toj.22.0036","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Diabetes is an immunocompromising condition, and diabetic children should receive the 23-valent pneumococcal polysaccharide (PPSV23) vaccine as part of their preventive care because of their increased risk for invasive pneumococcal disease. This recommendation is often not followed, however, and at our institution, we discovered that a factor limiting vaccine administration was lack of knowledge about the recommendation among residents. <b>Methods:</b> Our objective with this quality improvement initiative was to improve pneumococcal vaccination rates among the inpatient pediatric diabetic population to 70% in 6 months. Three education and awareness initiatives were conducted during the postintervention period of March 2021 to August 2021 at St. Mary Medical Center in Shreveport, Louisiana. All pediatric diabetic patients from age 2 to 18 years who were admitted to the inpatient general pediatrics or critical care services were included. The primary outcome was vaccination with PPSV23. <b>Results:</b> We studied 63 pediatric patients with a mean age of 12.7 years. The vaccination ordering rate during the 6 months prior to the implementation of the quality improvement initiatives was 41%. In the 6 months postintervention, the overall vaccination ordering rate improved to 81%. During data collection, however, we discovered that even though the residents were assessing for vaccine eligibility and ordering the vaccines, not all vaccines were administered prior to discharge. In the preintervention period, the overall vaccine administration rate was 27%, improving to 42% in the postintervention period. <b>Conclusion:</b> Simple interventions that included resident education, development of a smart phrase in the electronic medical record, and liaison with pharmacy led to an increase in the pneumococcal vaccination ordering rate for pediatric patients with diabetes. However, we did not anticipate that the vaccination ordering and administration rates would be different when we initiated the project and had therefore focused our interventions on resident education only. Our discovery of the difference between vaccination ordering and vaccination administration helped identify 2 other areas for improvement: nursing education and additional improvement of the electronic medical record.</p>","PeriodicalId":47600,"journal":{"name":"Ochsner Journal","volume":"22 3","pages":"239-243"},"PeriodicalIF":1.2000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477126/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ochsner Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31486/toj.22.0036","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 1

Abstract

Background: Diabetes is an immunocompromising condition, and diabetic children should receive the 23-valent pneumococcal polysaccharide (PPSV23) vaccine as part of their preventive care because of their increased risk for invasive pneumococcal disease. This recommendation is often not followed, however, and at our institution, we discovered that a factor limiting vaccine administration was lack of knowledge about the recommendation among residents. Methods: Our objective with this quality improvement initiative was to improve pneumococcal vaccination rates among the inpatient pediatric diabetic population to 70% in 6 months. Three education and awareness initiatives were conducted during the postintervention period of March 2021 to August 2021 at St. Mary Medical Center in Shreveport, Louisiana. All pediatric diabetic patients from age 2 to 18 years who were admitted to the inpatient general pediatrics or critical care services were included. The primary outcome was vaccination with PPSV23. Results: We studied 63 pediatric patients with a mean age of 12.7 years. The vaccination ordering rate during the 6 months prior to the implementation of the quality improvement initiatives was 41%. In the 6 months postintervention, the overall vaccination ordering rate improved to 81%. During data collection, however, we discovered that even though the residents were assessing for vaccine eligibility and ordering the vaccines, not all vaccines were administered prior to discharge. In the preintervention period, the overall vaccine administration rate was 27%, improving to 42% in the postintervention period. Conclusion: Simple interventions that included resident education, development of a smart phrase in the electronic medical record, and liaison with pharmacy led to an increase in the pneumococcal vaccination ordering rate for pediatric patients with diabetes. However, we did not anticipate that the vaccination ordering and administration rates would be different when we initiated the project and had therefore focused our interventions on resident education only. Our discovery of the difference between vaccination ordering and vaccination administration helped identify 2 other areas for improvement: nursing education and additional improvement of the electronic medical record.

Abstract Image

Abstract Image

提高住院儿童糖尿病患者肺炎球菌疫苗接种率
背景:糖尿病是一种免疫功能低下的疾病,糖尿病儿童应接种23价肺炎球菌多糖(PPSV23)疫苗,作为其预防保健的一部分,因为他们患侵袭性肺炎球菌疾病的风险增加。然而,这一建议通常不被遵循,在我们的机构,我们发现限制疫苗接种的一个因素是居民对建议缺乏了解。方法:我们的质量改进计划的目标是在6个月内将住院儿童糖尿病患者的肺炎球菌疫苗接种率提高到70%。在2021年3月至2021年8月干预后期间,在路易斯安那州什里夫波特的圣玛丽医疗中心开展了三项教育和提高认识举措。所有2至18岁的儿科糖尿病患者均被纳入普通儿科住院或重症监护服务。主要结果是PPSV23疫苗接种。结果:我们研究了63例儿童患者,平均年龄为12.7岁。在实施质量改进举措之前的6个月内,疫苗接种率为41%。干预后6个月,总体疫苗接种率提高到81%。然而,在数据收集过程中,我们发现,即使居民正在评估疫苗资格并订购疫苗,但并非所有疫苗都在出院前接种。在干预前阶段,总体疫苗接种率为27%,在干预后阶段提高到42%。结论:简单的干预措施,包括居民教育,在电子病历中开发智能短语,并与药房联系,导致儿童糖尿病患者肺炎球菌疫苗订购率的增加。然而,当我们启动该项目时,我们没有预料到疫苗接种订购率和管理率会有所不同,因此我们的干预措施只集中在居民教育上。我们发现疫苗接种顺序和疫苗接种管理之间的差异有助于确定另外两个需要改进的领域:护理教育和电子病历的进一步改进。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Ochsner Journal
Ochsner Journal MEDICINE, GENERAL & INTERNAL-
CiteScore
2.10
自引率
0.00%
发文量
71
审稿时长
24 weeks
期刊介绍: The Ochsner Journal is a quarterly publication designed to support Ochsner"s mission to improve the health of our community through a commitment to innovation in healthcare, medical research, and education. The Ochsner Journal provides an active dialogue on practice standards in today"s changing healthcare environment. Emphasis will be given to topics of great societal and medical significance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信